Industry perspective on the medical risk of visible particles in injectable drug products

PDA J Pharm Sci Technol. 2015 Jan-Feb;69(1):123-39. doi: 10.5731/pdajpst.2015.01037.
No abstract available

Publication types

  • Review

MeSH terms

  • Drug Contamination / prevention & control*
  • Drug Industry / standards*
  • Humans
  • Infusions, Intravenous / standards
  • Injections
  • Particle Size*
  • Pharmaceutical Preparations / analysis
  • Pharmaceutical Preparations / standards*
  • Risk Factors

Substances

  • Pharmaceutical Preparations